Omega Therapeutics, Inc. announced the appointment of Joshua Reed as Chief Financial Officer, effective May 23, 2022. Roger Sawhney, M.D., Omega's Chief Financial Officer, will serve as Chief Business Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | -1.48% | +1.01% | -33.55% |
05-30 | Omega Therapeutics, Inc. Announces Termination of Yan Moore as Chief Medical Officer | CI |
05-29 | Omega Therapeutics, Inc. Appoints Kaan Certel, Ph.D., as Chief Business Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.55% | 110M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Omega Therapeutics, Inc. Announces Executive Changes